INmune Bio, Inc. (INMB)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 04, 13:58
INmune Bio Price : 1.31 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 1.40 | 1.42 | 1.30 | 1.32 | 235733.0 |
| Nov 02, 2026 | 1.47 | 1.49 | 1.365 | 1.38 | 203571.0 |
| Oct 30, 2026 | 1.53 | 1.555 | 1.43 | 1.45 | 184101.0 |
| Oct 29, 2026 | 1.53 | 1.65 | 1.53 | 1.60 | 185886.0 |
| Oct 28, 2026 | 1.50 | 1.53 | 1.46 | 1.53 | 188540.0 |
| Oct 27, 2026 | 1.41 | 1.53 | 1.40 | 1.52 | 274778.0 |
| Oct 26, 2026 | 1.47 | 1.49 | 1.41 | 1.43 | 162787.0 |
| Oct 23, 2026 | 1.53 | 1.53 | 1.45 | 1.46 | 190564.0 |
| Oct 22, 2026 | 1.58 | 1.63 | 1.52 | 1.54 | 220704.0 |
| Oct 21, 2026 | 1.61 | 1.69 | 1.60 | 1.61 | 229971.0 |
| Oct 20, 2026 | 1.53 | 1.63 | 1.53 | 1.60 | 75600.00 |
| Oct 19, 2026 | 1.58 | 1.58 | 1.510 | 1.54 | 156577.0 |
| Oct 16, 2026 | 1.68 | 1.68 | 1.56 | 1.57 | 196169.0 |
| Oct 15, 2026 | 1.60 | 1.68 | 1.53 | 1.65 | 628019.0 |
| Oct 14, 2026 | 1.70 | 1.915 | 1.59 | 1.60 | 1.137M |
| Oct 13, 2026 | 1.77 | 1.79 | 1.64 | 1.68 | 247264.0 |
| Oct 12, 2026 | 1.89 | 1.89 | 1.78 | 1.78 | 72743.00 |
| Oct 09, 2026 | 1.84 | 1.91 | 1.84 | 1.89 | 91631.00 |
| Oct 08, 2026 | 1.85 | 1.87 | 1.79 | 1.83 | 379165.0 |
| Oct 07, 2026 | 1.82 | 1.88 | 1.82 | 1.86 | 104378.0 |
| Oct 06, 2026 | 1.95 | 1.978 | 1.82 | 1.87 | 311074.0 |
| Oct 05, 2026 | 1.90 | 1.97 | 1.88 | 1.94 | 267250.0 |
| Oct 02, 2026 | 1.97 | 1.999 | 1.93 | 1.93 | 290238.0 |
| Oct 01, 2026 | 1.96 | 1.97 | 1.88 | 1.93 | 340814.0 |
| Sep 30, 2026 | 1.98 | 2.02 | 1.94 | 1.95 | 201903.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 61.77 |
| Oncolytics Biotech, Inc. | 0.4184 |
| Sangamo Therapeutics, Inc. | 0.117 |
| Sarepta Therapeutics, Inc. | 19.08 |
| Anixa Biosciences, Inc. | 3.13 |
Price Related Metrics
| Price to Book Value | 1.711 |
| Earnings Yield | -52.85% |
| Market Cap | 36.23M |